BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 8, 2008
View Archived Issues
Nuclear orphan receptor Nur77 can be targeted with cytosporone B
Read More
Amgen targets BKCa channel for migraine treatment
Read More
Wyeth creates novel series of selective norepinephrine reuptake inhibitors
Read More
Federal Trade Commission clears Frensenius' acquisition of APP Pharmaceuticals
Read More
Debiopharm and EPFL initiate research project Debio 0826 in cancer
Read More
Evotec achieves third milestone under drug discovery contract with Boehringer Ingelheim
Read More
Dr. Reddy's signs agreements with Antares and Cosmederm for dermatology products
Read More
Preclinical study with AZD-6140 shows antiplatelet effect in a canine model of coronary thrombosis
Read More
Acucela and Otsuka establish codevelopment agreement for rebamipide
Read More
SIGA awarded contract to develop new smallpox indications for ST-246
Read More
Human Genome Sciences and Hospira sign manufacturing process development deal
Read More
Epix to regain worldwide commercialization rights to Vasovist
Read More
Priority review for ATryn BLA
Read More
Emergent receives USD 24 million contract from the HSS to develop AVP-21D9
Read More
Camurus and Wyeth sign option and license agreement in hemophilia therapeutics
Read More
Novel treatments for respiratory disorders disclosed in recent Merck Frosst patent
Read More
BioCryst presents results from BCX-4208 phase IIa trial in psoriasis
Read More
BioMS Medical's dirucotide granted FDA fast track for multiple sclerosis
Read More
Idenix reports results from proof-of-concept study for IDX-899 in HIV
Read More
Recent patents describe new treatment options for immunological disorders
Read More
ProtAffin granted FDA orphan drug designation for PA-401 in transplantation
Read More
Novel antiinflammatory agents claimed in recent Boehringer Ingelheim patent
Read More
Toctino (alitretinoin) receives marketing authorization in the U.K.
Read More
Yaz, a new low-dose oral contraceptive, launched in Europe by Bayer Schering Pharma
Read More